Geode Capital Management’s VIVEVE MED INC VIVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-51,355
| Closed | -$21K | – | 4937 |
|
|
2022
Q4 | $21K | Hold |
51,355
| – | – | ﹤0.01% | 4762 |
|
|
2022
Q3 | $34K | Hold |
51,355
| – | – | ﹤0.01% | 4835 |
|
|
2022
Q2 | $33K | Hold |
51,355
| – | – | ﹤0.01% | 4858 |
|
|
2022
Q1 | $54K | Hold |
51,355
| – | – | ﹤0.01% | 4792 |
|
|
2021
Q4 | $58K | Sell |
51,355
-32
| -0.1% | -$59 | ﹤0.01% | 4834 |
|
|
2021
Q3 | $117K | Buy |
51,387
+9,201
| +22% | +$23.1K | ﹤0.01% | 4630 |
|
|
2021
Q2 | $124K | Buy |
42,186
+20,019
| +90% | +$56.3K | ﹤0.01% | 4502 |
|
|
2021
Q1 | $67K | Buy |
+22,167
| New | +$81.4K | ﹤0.01% | 4369 |
|
|
2019
Q3 | – | Sell |
-243
| Closed | -$92K | – | 4247 |
|
|
2019
Q2 | $92K | Buy |
243
+26
| +12% | +$14.1K | ﹤0.01% | 3980 |
|
|
2019
Q1 | $203K | Hold |
217
| – | – | ﹤0.01% | 3741 |
|
|
2018
Q4 | $227K | Buy |
217
+26
| +14% | +$62.4K | ﹤0.01% | 3635 |
|
|
2018
Q3 | $510K | Buy |
191
+3
| +2% | +$8.5K | ﹤0.01% | 3459 |
|
|
2018
Q2 | $510K | Buy |
188
+24
| +15% | +$69.1K | ﹤0.01% | 3436 |
|
|
2018
Q1 | $599K | Buy |
164
+59
| +56% | +$257K | ﹤0.01% | 3339 |
|
|
2017
Q4 | $523K | Hold |
105
| – | – | ﹤0.01% | 3343 |
|
|
2017
Q3 | $551K | Buy |
105
+2
| +2% | +$12.3K | ﹤0.01% | 3324 |
|
|
2017
Q2 | $738K | Buy |
103
+68
| +194% | +$507K | ﹤0.01% | 3224 |
|
|
2017
Q1 | $223K | Hold |
35
| – | – | ﹤0.01% | 3622 |
|
|
2016
Q4 | $181K | Hold |
35
| – | – | ﹤0.01% | 3647 |
|
|
2016
Q3 | $254K | Buy |
+35
| New | +$232K | ﹤0.01% | 3513 |
|
Other funds holding VIVE
Geode Capital Management's VIVE Position: Q1 2023 in Review
Geode Capital Management sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 51,355 shares — an estimated $21K sold.
Geode Capital Management first reported a position in VIVE in Q3 2016 and held it in 20 quarters. The position peaked at $738K in Q2 2017. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.
- Geode Capital Management reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
- Geode Capital Management sold 51,355 VIVEVE MED INC shares in Q1 2023, an estimated $21K.
- Geode Capital Management first reported a position in VIVEVE MED INC in Q3 2016 and held it in 20 quarters.
- Geode Capital Management's VIVEVE MED INC position peaked at $738K in Q2 2017.
- 1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.